Optimizing Early-Stage Drug Discovery through Project Management: Evaluating the Strategic Value of Early Project Manager Assignments in the Pharmaceutical Sector

Sowmya Sunkara; Desfriana Sari

doi:10.61536/escalate.v3i02.304

Authors

Sowmya Sunkara BMS College of Engineering
Desfriana Sari Sekolah Tinggi Ilmu Ekonomi KBP

DOI:

https://doi.org/10.61536/escalate.v3i02.304

Keywords:

Early Drug Discovery; Project Management; Pharmaceutical R&D; Pre-Lead Optimization; Project Leadership

Abstract

The effectiveness of pharmaceutical research and development increasingly relies on aligning scientific innovation with structured operational management. This study examines the strategic impact of assigning project managers (PMs) during the early stages of drug discovery, particularly in the pre-lead optimization (pre-LO) phase. Employing a mixed-methods design that combines semi-structured interviews, document analysis, and quantitative surveys, the research compares key performance indicators between pre-LO and post-lead optimization (post-LO) teams. Quantitative and qualitative findings demonstrate that the absence of dedicated PMs in early discovery results in fragmented communication, unclear role expectations, and weak cross-functional coordination. In contrast, post-LO teams with PM involvement report higher levels of goal alignment, structured decision-making, and operational clarity. Statistical and thematic analyses reveal that PM competencies in communication, facilitation, and strategic alignment are more influential on project success than technical or scientific expertise. The study proposes a conceptual framework emphasizing the early integration of project management practices to enhance collaboration, mitigate risks, and streamline transitions from discovery to development. These insights offer both theoretical contributions to pharmaceutical project governance and practical recommendations for improving R&D productivity through early-phase project leadership.

Downloads

Download data is not yet available.

References

Bartlett, C. A., & Ghoshal, S. (2019). Managing Across Borders: The Transnational Solution. Harvard Business Review Press.

Blass, E., & Hayward, P. (2014). Innovation in project management: The role of leadership in cross-functional teams. International Journal of Project Management, 32(4), 663–672. https://doi.org/10.1016/j.ijproman.2013.09.001

Chien, C. H., & Yu, C. C. (2021). Cross-functional integration in pharmaceutical R&D: The moderating role of project managers. Journal of Business Research, 134, 135–143. https://doi.org/10.1016/j.jbusres.2021.05.004

DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016). Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20–33. https://doi.org/10.1016/j.jhealeco.2016.01.012

Dyer, J. H., Gregersen, H. B., & Christensen, C. M. (2019). The Innovator’s DNA: Mastering the Five Skills of Disruptive Innovators. Harvard Business Review Press.

Fernandes, G., Ward, S., & Araújo, M. (2015). Improving and embedding project management practice in organisations – A qualitative study. International Journal of Project Management, 33(5), 1052–1067. https://doi.org/10.1016/j.ijproman.2015.01.012

Hall, L. H., & Rosenthal, M. B. (2021). Balancing innovation and evidence: The role of project leaders in early-phase drug development. Health Affairs, 40(10), 1574–1580. https://doi.org/10.1377/hlthaff.2021.00762

Hussain, M., & Ali, S. (2020). Agile project management practices in pharmaceutical innovation. Journal of Project Management, 5(1), 25–34. https://doi.org/10.5267/j.jpm.2019.7.003

Macdonald, S. J. F., & McCulloch, J. (2021). Strategic alignment in early-stage drug development: Project managers as knowledge integrators. Drug Discovery Today, 26(2), 433–441. https://doi.org/10.1016/j.drudis.2020.11.005

Milosevic, D. Z., & Srivannaboon, S. (2018). Project Management ToolBox: Tools and Techniques for the Practicing Project Manager (2nd ed.). Wiley.

Müller, R., & Turner, J. R. (2017). The influence of project managers on project success criteria and project success by type of project. European Management Journal, 35(3), 322–330. https://doi.org/10.1016/j.emj.2016.10.008

Paul, S. M., et al. (2019). How to improve R&D productivity: The pharmaceutical industry's grand challenge. Nature Reviews Drug Discovery, 18, 203–216. https://doi.org/10.1038/s41573-018-0001-1

Pérez, V., & Montes, A. (2022). Managing uncertainty in early drug discovery: A systems-based project framework. Journal of Pharmaceutical Innovation, 17(1), 112–123. https://doi.org/10.1007/s12247-021-09541-y

Pinto, J. K., & Winch, G. (2016). The unsettling of 'settled science': The role of project management in drug discovery. Research Policy, 45(1), 255–264. https://doi.org/10.1016/j.respol.2015.09.007

Pritchard, C. L. (2021). Risk Management: Concepts and Guidance (6th ed.). CRC Press.

Santos, D. (2019). Escalating the Value of Project Management in Early-Drug Discovery. Internal Unpublished Report.

Schmidt, R., & Lyytinen, K. (2020). Project governance in complex pharmaceutical innovation ecosystems. Technovation, 98, 102147. https://doi.org/10.1016/j.technovation.2020.102147

Turner, J. R. (2016). Gower Handbook of Project Management (5th ed.). Routledge.

Viana, M., Solans, R., & Castañé, M. (2022). Facilitating drug discovery through agile project management: A case study in pharmaceutical R&D. Journal of Pharmaceutical Innovation, 17(2), 210–224. https://doi.org/10.1007/s12247-021-09553-8

Zwikael, O., & Meredith, J. R. (2019). Evaluating the success of a project and the performance of its leaders. IEEE Transactions on Engineering Management, 66(3), 442–455. https://doi.org/10.1109/TEM.2018.2868945